Back to top
Top
U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

All eCQMs associated with: Proportion measure

Year Type CMS eCQM ID Measure Name
2024 EC CMS128v12 Anti-depressant Medication Management
2022 EC CMS129v11 Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
2023 EC CMS129v12 Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
2024 EC CMS129v13 Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
2022 EC CMS130v10 Colorectal Cancer Screening
2023 EC CMS130v11 Colorectal Cancer Screening
2024 EC CMS130v12 Colorectal Cancer Screening
2022 EC CMS131v10 Diabetes: Eye Exam
2023 EC CMS131v11 Diabetes: Eye Exam
2024 EC CMS131v12 Diabetes: Eye Exam
2022 EC CMS133v10 Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
2023 EC CMS133v11 Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
2024 EC CMS133v12 Cataracts: 20 over 40 or Better Visual Acuity within 90 Days Following Cataract Surgery
2022 EC CMS134v10 Diabetes: Medical Attention for Nephropathy
2022 EC CMS135v10 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2023 EC CMS135v11 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2024 EC CMS135v12 Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2022 EC CMS136v11 Follow-Up Care for Children Prescribed ADHD Medication (ADD)
2023 EC CMS136v12 Follow-Up Care for Children Prescribed ADHD Medication (ADD)
2024 EC CMS136v13 Follow-Up Care for Children Prescribed ADHD Medication (ADD)